It might seem convenient, but as we've covered, it's a major violation of proper protocol
With Transcend, Lilly had a full picture of data, to the point that they published the data in The Lancet, but the trial was only 40 weeks long and multiple endpoints including A1c, weight loss and other markers havent quite hit the full potential of the drug for diabetics so were left with questions on what happens when you take it for a longer term
Is oral glutathione safer than IV glutathione
10.1038/s41586-024-07516-8 11 CamilleC.Goff OcaneL.FrdricS.VasseurF.TanouM.NguyenC.et al (2021)
Oral glutathione is generally well-tolerated with only mild side effects reported
Alberti KG, Johnston DG, Gill A, et al